On September 28, 2023, Yunnan Jianzhijia Chongqing Qinkang Pharmaceutical Co., Ltd. closed the transaction. The company announced that it has completed the change registration procedures, and obtained a new "Business License". The registered capital of the company is CNY 80 million.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
26.87 CNY | -3.86% |
|
-12.19% | -45.72% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-45.72% | 595M | |
-45.40% | 9.23B | |
-25.00% | 6.9B | |
-6.51% | 6.05B | |
+83.43% | 4.87B | |
-3.80% | 4.55B | |
-23.25% | 4.44B | |
+2.24% | 4.34B | |
-18.33% | 2.59B | |
-11.63% | 2.57B |
- Stock Market
- Equities
- 605266 Stock
- News Jianzhijia Pharmaceutical Chain Group Co., Ltd.
- Yunnan Jianzhijia Chongqing Qinkang Pharmaceutical Co., Ltd. announced that it has received CNY 50 million in funding from Jianzhijia Pharmaceutical Chain Group Co., Ltd.